FDA NEWS RELEASE: FDA: Risk of oral birth defects in children born to mothers taking topiramate. "New data suggest that the drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration said today." See your OB/GYN for more information.
Answered 11/14/2018
3.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
7 doctors weighed in across 2 answers
7 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question